Inventor · disambiguated record
Oliver Boscheinen
Also filed as: BOSCHEINEN OLIVER
2 granted patents·16 pending applications·8 citations·filing 2011–2024
56Inventor score
Top patents by PatentIndex Score
18 records- 0189US10583174B2FGF21 compound / GLP-1R agonist combinations with optimized activity ratioSANOFI SA·Filed 2017·Granted Mar 10, 2020·6 cites·22 claims
- 0283US11230582B2FGF21 variantsSANOFI SA·Filed 2016·Granted Jan 25, 2022·2 cites·6 claims
- 0379US2024366727A1Fgf21 compound / glp-1r agonist combinations with optimized activity ratioSANOFI SA·Filed 2024·Application pending·0 cites
- 0477US2025171512A1Fgf21 variantsSANOFI SA·Filed 2024·Application pending·0 cites
- 0571US2022401523A1Fgf21 compound / glp-1r agonist combinations with optimized activity ratioSANOFI SA·Filed 2022·Application pending·0 cites
- 0666US2022227825A1Fgf21 variantsSANOFI SA·Filed 2021·Application pending·0 cites
- 0760US2020261542A1Fgf21 compound / glp-1r agonist combinations with optimized activity ratioSANOFI SA·Filed 2020·Application pending·0 cites
- 0856US2018236033A1Pharmaceutical composition for treating a metabolic syndromeSANOFI SA·Filed 2018·Application pending·0 cites
- 0953US2019085043A1Fusion proteins for treating a metabolic syndromeSANOFI SA·Filed 2018·Application pending·0 cites
- 1051US2014073563A1Fusion proteins for treating a metabolic syndromeBOSCHEINEN OLIVER·Filed 2013·Application pending·0 cites
- 1150US2023346949A1A method of forming a conjugate of a sulfonamide and a polypeptideSANOFI SA·Filed 2020·Application pending·0 cites
- 1250US2016279199A1Pharmaceutical composition for treating a metabolic syndromeSANOFI SA·Filed 2016·Application pending·0 cites
- 1349US2023250147A1Glp-1r agonistic peptides with reduced activitySANOFI SA·Filed 2020·Application pending·0 cites
- 1449US2013203651A1Pharmaceutical composition for treating a metabolic syndromeSOMMERFELD MARK·Filed 2011·Application pending·0 cites
- 1549US2023265152A1Glp-1r agonist / fgf21 fusion proteinsSANOFI SA·Filed 2020·Application pending·0 cites
- 1647US2015231210A1Pharmaceutical Composition for Treating a Metabolic SyndromeSANOFI SA·Filed 2015·Application pending·0 cites
- 1746US2016194371A1Fusion proteins comprising FGF-21 and GLP-1R agonistSANOFI SA·Filed 2015·Application pending·0 cites
- 1837US2014142023A1Pharmaceutical Composition for Treating A Metabolic SyndromeSOMMERFELD MARK·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Oliver Boscheinen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →